GB1125409A - Pharmaceutical compositions containing sulphoxides - Google Patents

Pharmaceutical compositions containing sulphoxides

Info

Publication number
GB1125409A
GB1125409A GB3380266A GB3380266A GB1125409A GB 1125409 A GB1125409 A GB 1125409A GB 3380266 A GB3380266 A GB 3380266A GB 3380266 A GB3380266 A GB 3380266A GB 1125409 A GB1125409 A GB 1125409A
Authority
GB
United Kingdom
Prior art keywords
sulphoxides
compositions
penetrant
aliphatic
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3380266A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1125409A publication Critical patent/GB1125409A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB3380266A 1965-08-02 1966-07-27 Pharmaceutical compositions containing sulphoxides Expired GB1125409A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47667665A 1965-08-02 1965-08-02

Publications (1)

Publication Number Publication Date
GB1125409A true GB1125409A (en) 1968-08-28

Family

ID=23892803

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3380266A Expired GB1125409A (en) 1965-08-02 1966-07-27 Pharmaceutical compositions containing sulphoxides

Country Status (5)

Country Link
BE (1) BE684960A (enExample)
FR (2) FR5698M (enExample)
GB (1) GB1125409A (enExample)
IL (1) IL26210A (enExample)
NL (1) NL6610878A (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888164A (en) * 1985-12-27 1989-12-19 L'oreal Cosmetic composition for the treatment of oily skin and hair based on di(beta-hydroxyethyl) sulfoxide and the use thereof
EP1693052A1 (en) * 2001-10-03 2006-08-23 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
US9271931B2 (en) 2001-10-03 2016-03-01 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
US10058507B2 (en) 2001-10-03 2018-08-28 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984480A (en) * 1970-05-12 1976-10-05 L'oreal Polyhydroxyl monosulfoxide surfactant

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888164A (en) * 1985-12-27 1989-12-19 L'oreal Cosmetic composition for the treatment of oily skin and hair based on di(beta-hydroxyethyl) sulfoxide and the use thereof
EP1693052A1 (en) * 2001-10-03 2006-08-23 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
US9271931B2 (en) 2001-10-03 2016-03-01 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
US10058507B2 (en) 2001-10-03 2018-08-28 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
US10722464B2 (en) 2001-10-03 2020-07-28 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations

Also Published As

Publication number Publication date
FR1505490A (fr) 1967-12-15
BE684960A (enExample) 1967-02-02
NL6610878A (enExample) 1967-02-03
FR5698M (enExample) 1968-02-19
IL26210A (en) 1970-12-24

Similar Documents

Publication Publication Date Title
US4424232A (en) Treatment of herpes simplex
US4536404A (en) Method and composition for treating post-herpetic neuralgia
KR880000091A (ko) 국소용 약제학적 조성물 이의 제조방법 및 이의 용도
ES8702784A1 (es) Un procedimiento para preparar una composicion anticaspa a base de una sal de 1-hidroxi-2-piridintiona y una hidroxipiridona.
IT1210589B (it) Procedimento per la preparazione dicomposti pirimidinici dotati di attivita' farmacologica particolarmente per il trattamento di infezioni batteriche loro intermedi prodotto ottenuto e composizioni farmaceutiche che li contengono
NZ241494A (en) Personal care formulation that contains an anti-microbial agent which is a thiohydroxamic acid derivative or a heterocyclic thione
DK408987D0 (da) Phenoxyeddikesyrederivater samt fremstilling deraf
FR2398732A1 (fr) Nouveau sel d'aluminium soufre, son procede de preparation et compositions cosmetiques et pharmaceutiques le contenant
GB1125409A (en) Pharmaceutical compositions containing sulphoxides
KR900013969A (ko) 지루를 감소시키는 약학 조성물의 제조에 있어서 5'-데옥시-5'-메틸티오아데노신, s-아데노실메티오닌 및 이들의 염의 용도 및 이와 관련된 약학 조성물
GB1125410A (en) Pharmaceutical compositions containing sulphones
IT1193747B (it) Composizioni e accorgimenti perfezionati per l'inibizione della formazione di composti esplosivi e dicondizioni di esplosivita' nei concentrati per argentatura per la deposizione chimica dell'argento senza passaggio di corrente
IT7829910A0 (it) Derivati dell'acido fosfonoso, procedimenti per la loro preparazione e loro impiego per combattere microorganismi.
JPS5781486A (en) Benzo(ij)quinolidine-2-carboxylic acid derivative
KR920700627A (ko) 치료제로서 1-페닐-2-아미노에탄올 유도체의 신규한 용도
DE3063525D1 (en) Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
ES2000681A6 (es) Un procedimiento para preparar nuevos compuestos de bencilpiperazina
KR890006665A (ko) 항-hiv 활성, 3'-아지도-2,6-디아미노푸린-2',3'-디데옥시리보사이드
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
EP0377413B1 (en) Pharmaceutical compositions having topical use comprising ticlopidine
ES472528A1 (es) Procedimiento para la preparacion de derivados de benzosul- fonamida
SE8404560L (sv) Saneringskomposition
GB955766A (en) New thioethers and process for their manufacture
US3904765A (en) Process for controlling lamellar dystrophy of fingernails